Blog Coverage AMETEK Acquires Rauland-Borg for $340 Million

Upcoming AWS Coverage on Roper Technologies Post-Earnings Results

LONDON, UK / ACCESSWIRE / February 8, 2017 / Active Wall St. blog coverage looks at the headline from AMETEK, Inc. (NYSE: AME) as the Company announced on February 07, 2017, that it has completed the acquisition of Rauland-Borg Corporation, a leading provider of mission-critical communication solutions for hospitals, healthcare institutions, and educational establishments. The annual revenues for the acquired Company stood at approximately $160 million. Register with us now for your free membership and blog access at:

http://www.activewallst.com/register/

One of AMETEK's competitors within the Diversified Machinery space, Roper Technologies, Inc. (NYSE: ROP), announced on January 13, 2017, that its financial results for Q4 2016, ended December 31, 2016, will be released before the market opens on Thursday, February 09, 2017. A conference call to discuss these results has been scheduled for 8:30 AM ET on the same day. AWS will be initiating a research report on Roper Technologies in the coming days.

Today, AWS is promoting its blog coverage on AME; touching on ROP. Get all of our free blog coverage and more by clicking on the links below:

http://www.activewallst.com/registration-3/?symbol=AME

http://www.activewallst.com/registration-3/?symbol=ROP

The Agreement

Rauland-Borg, headquartered at Mount Prospect, Illinois, joins Ametek as part of its Electronic Instruments Group (EIG). EIG is the leader in advanced analytical, monitoring, calibrating, testing, and display instruments with annual sales amounting to $2.4 billion. Ametek acquired Rauland-Borg for $340 million, with $30 million in a potential contingent payment subject to achievement of certain milestones. Ametek views this acquisition as penetration into a new growth segment, the medical technology market. The agreement comes with potential growth opportunities through international expansions according to David A. Zapico, CEO of AMETEK.

Rauland Responder

Rauland Responder critical solutions enhance the communication and workflow within a hospital-patient-to-staff and staff-to-staff. Responder enables the staff to deliver the best possible patient care, with flexible integration, intelligent call routing, and real-time reporting. It helps data collection in real-time to enhance the decision-making process. Recently, on January 24, 2017, Rauland-Borg brought the integration of Rauland Responder All Touch with Connexall's clinical communication software platform. Using the integration, both Responder and Connexall exchange inter-related events to develop best practices for room-based workflows.

AMETEK's Growth Strategy

AMETEK probably believes in a growth formula derived from acquisitions. It acquired Surface Inspection Systems Division (SISD) from Cognex Corporation (NASDAQ: CGNX) for approximately $160 million. Complementary to AMETEK's EIG portfolio, SISD's proprietary real-time image processing technology expanded the Company's capabilities in the non-destructive process inspection market.

On November 01, 2016, AMETEK announced the execution of acquisition of Laserage Technology Corporation, a provider of Laser Fabrication Services for the medical devices market. The privately held company, Laserage, reported estimated annual sales of $22 million. The acquisition was viewed as an expansion of fabrication and manufacturing capabilities under its engineered medical components business. Laserage joined the Company as a part of its Electromechanical Group (EMG).

AMETEK Q4 FY16 Results

AMETEK reported its Q4 FY16 results on February 07, 2016. The Company reported net sales of $973 million for the three-month period, ending December 31, 2016. The operating income for Q4 FY16 was $173.3 million, and diluted EPS were $0.47 on a GAAP basis. Excluding adjustments of $39.5 million, or $0.11 per diluted share, Q4 FY16 operating income stood at $212.7 million and diluted EPS of $0.58. The operating cash flow $247 million for Q4 FY16 was a 24% surge over the cash flow for Q4 FY15.

Stock Performance

On Tuesday, February 07, 2017, the stock closed the trading session at $51.68, slightly rising 0.04% from its previous closing price of $51.66. A total volume of 4.78 million shares have exchanged hands, which was higher than the 3-month average volume of 2.06 million shares. AMETEK's stock price advanced 16.64% in the last three months, 10.18% in the past six months, and 16.36% in the previous twelve months. Furthermore, since the start of the year, shares of the Company have gained 6.34%. The stock is trading at a PE ratio of 22.56 and has a dividend yield of 0.70%. The net market capital for the firm stood at $11.85 billion.

Active Wall Street:

Active Wall Street (AWS) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. AWS has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

AWS has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer") represented by a credentialed financial analyst, for further information on analyst credentials, please email info@activewallst.com. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by AWS. AWS is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

AWS, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. AWS, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, AWS, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither AWS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.activewallst.com/disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@activewallst.com

Phone number: 1-858-257-3144

Office Address: 3rd floor, 207 Regent Street, London, W1B 3HH, United Kingdom

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active Wall Street

ReleaseID: 454630

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.